Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
16 results
  1. Detailed Methods - Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: A Systematic Review ... 
    https://www.ncbi.nlm.nih.gov/books/NBK542912
    ... et al. Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: ... et al. Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana. J Antimicrob ...
  2. Quantitative Synthesis—An Update - Methods Guide for Effectiveness and Comparative Effectiveness Reviews - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK519365
    ... antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet. ...
  3. Conducting Quantitative Synthesis When Comparing Medical Interventions: AHRQ and the Effective Health Care Program - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK49407
    ... antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet. ...
  4. Assessing Harms When Comparing Medical Interventions - Methods Guide for Effectiveness and Comparative Effectiveness ... 
    https://www.ncbi.nlm.nih.gov/books/NBK47098
    ... antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet. ...
  5. HIV Medicines | HIV Cure | HIV Treatment | MedlinePlus 
    https://medlineplus.gov/hivmedicines.html
    ... inhibitors (NRTIs) block an enzyme called reverse transcriptase Non-nucleoside reverse transcriptase inhibitors (NNRTIs) bind to and later change reverse transcriptase ...
  6. Kaposi Sarcoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65897
    ... et al.: A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. ...
  7. NLM Digital Collections - Eighth (Amsterdam, Netherlands), 1992 Jul 19-24 
    https://resource.nlm.nih.gov/101647507X229
    ... controlled studies of d4T are currently in progress®, NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Anumber of non-nucleoside Reverse Transcriptase inhibitors have ...
  8. NLM Digital Collections - American Red Cross, 1992 
    https://resource.nlm.nih.gov/101647507X142
    ... resistance problems encountered in early testing of other non-nucleoside reverse transcriptase inhibitors, Upjohn reported. The company explained that studies performed. ...
  9. NLM Digital Collections - Future Directions in AIDS Research (Madison, WI), 1993 July 30-31 
    https://resource.nlm.nih.gov/101647507X92
    ... research-based pharmaceutical companies are continuing Teseaich with non-nucleoside reverse transcriptase inhibitors, protease inhibitors, tat inhibitors, and nucleoside reverse transcriptase ...
  10. NLM Digital Collections - Trends in retail prices of specialty prescription drugs widely used by older Americans : 2017 ... 
    Publication: Washington, DC : AARP Public Policy Institute, June 2019
    resource.nlm.nih.gov/101769462
    ... JAK Inhibitors JAK – Janus Kinase Antiretrovirals – NNRTI NNRTI – Non-Nucleoside Reverse Transcriptase Inhibitors TRENDS IN RE TAIL PRICES OF SPECIALT Y ...
previous · 1 · 2 · next